Search

everythinglearnresearchcommunity

for

Search:↓

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

A boy with alopecia regrew hair using a vitamin D cream after other treatments failed.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Oral minoxidil shows promise in treating monilethrix-related hair loss.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Genetic factors alone might not cause pemphigus vulgaris; other factors like birth complications and puberty may trigger it.

Different treatments for alopecia areata have unpredictable results and varying success rates.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

New methods have helped find cells that create other cells in the body.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Using a nonablative fractional laser with topical minoxidil can effectively and safely promote hair regrowth in alopecia areata patients.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

The study found that polymorphous light eruption varies among patients and can be distinguished from benign summer light eruption by the time it takes for symptoms to appear after sun exposure.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Using existing drugs for new treatments is cost-effective and safer.

Papular acantholytic dyskeratosis of the vulva is a rare, benign skin condition that can be managed conservatively.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.